...
首页> 外文期刊>Journal of neurointerventional surgery >A systematic review and meta-analysis of observational evidence for the use of bailout self-expandable stents following failed anterior circulation stroke thrombectomy
【24h】

A systematic review and meta-analysis of observational evidence for the use of bailout self-expandable stents following failed anterior circulation stroke thrombectomy

机译:在失败前循环中风血栓切除术后,系统审查和荟萃分析用于使用失败的前循环中风血栓切除术后的救助自膨胀支架

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background The crucial role of thrombectomy in the management of emergent large vessel occlusive stroke is not disputed but there is a technical failure rate in a significant minority of patients whose outcomes are often poor. Our objective was to perform a systematic review and meta-analysis to assess the safety and efficacy of permanent self-expandable stent deployment as a bailout procedure in cases of failed anterior circulation thrombectomy. Methods Two independent reviewers searched the Pubmed (Medline) database for studies reporting outcomes following failed endovascular thrombectomy with subsequent rescue therapy employing self-expandable stents. Results Eight studies (one prospective, seven retrospective) originating from Europe, Asia, and America comprising 160 patients met the inclusion criteria. Estimated baseline National Institutes of Health Stroke Scale score was 17.1 (95% CI 15.7 to 18.4). Following failed thrombetcomy and stent deployment, the rate of favorable outcome (modified Rankin Scale score 0-2) was 43% (95% CI 34% to 53%). Pooled mortality was 21% (95% CI 13% to 33%). Successful recanalization (Thrombolysis in Cerebral Infarction (TICI) 2b-3 or Thrombolysis in Myocardial Infarction (TIMI) 2-3) was 71% (95% CI 63% to 77%). Symptomatic intracerebral hemorrhage was seen in 12% (95% CI 7% to 18%). The Solitaire stent (Medtronic) was the most commonly deployed stent following failed thrombectomy attempts (66%; 95% CI 31% to 89%). Pre- or post-stent angioplasty was performed in 39%of patients (95% CI 29% to 48%). Glycoprotein IIb/IIIa inhibitors were used in 89% (95% CI 71% to 97%). 95% of patients received postprocedural antiplatelet therapy. Conclusion A rescue stent procedure seems reasonable as a last resort following failed thrombectomy but currently the level of evidence is limited. Prospective registries may aid in guiding future recommendations.
机译:背景技术血栓切除术在突出的大型船舶闭塞行程管理中的关键作用并不有争议,但在少数少数患者中,少数患者往往是较差的技术失败率。我们的目标是进行系统审查和荟萃分析,以评估永久性自我扩张支架部署作为救助程序的安全性和有效性,因为前循环发生故障血液切除术病例。方法两种独立审阅者搜查了Pubmed(Medline)数据库,用于研究失败的血管内血液切除术后的报告结果,随后救援治疗采用自膨胀支架。结果八项源自欧洲,亚洲和美国的研究(一位前瞻性,七次回顾性),包括160名患者的纳入标准。估计基线国家卫生院校卒中量表得分为17.1(95%CI 15.7至18.4)。在失败的血栓组件和支架部署之后,有利的结果(改进的Rankin比分0-2)的速度为43%(95%CI 34%至53%)。合并的死亡率为21%(95%CI 13%至33%)。成功的重新化(脑梗死溶栓(TiCi)2b-3或心肌梗死(Timi)2-3的溶栓分析为71%(95%CI 63%至77%)。在12%(95%CI〜18%95%CI至18%)中看到症状脑内出血。粒子切除术企图失败(66%; 95%CI 31%至89%)中,Solitaire支架(Medtronic)是最常见的支架。在39%的患者中进行预期或后支撑后血管成形术(95%CI 29%至48%)。糖蛋白IIB / IIIa抑制剂以89%(95%CI 71%至97%)使用。 95%的患者接受了后预抗血小板治疗。结论救援支架程序似乎是血栓切除术失败后的最后手段,但目前证据水平有限。预期注册机构可以帮助指导未来的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号